Meta-analysis of short vs. prolonged dual antiplatelet therapy after drug-eluting stent implantation and role of continuation with either aspirin or a P2Y12 inhibitor …
S Lahu, P Bristot, S Gewalt, A Goedel… - … of Atherosclerosis and …, 2022 - jstage.jst.go.jp
… P2Y12 inhibitor therapy, our analysis did also show that patients who continued with aspirin
were … higher in the P2Y12 monotherapy trials as compared to the aspirin monotherapy trials. …
were … higher in the P2Y12 monotherapy trials as compared to the aspirin monotherapy trials. …
[PDF][PDF] Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention
LFL Tanajura, ÁJ Chaves, RP Freitas, ABAR Barbosa… - jotci.org
… of acetylsalicylic acid and a P2Y12 platelet receptor inhibitor, … P2Y12 receptor inhibitor and
maintaining acetylsalicylic acid … the digestive tract, P2Y12 inhibitors have been considered a …
maintaining acetylsalicylic acid … the digestive tract, P2Y12 inhibitors have been considered a …
Ideal P2Y12 inhibitor in acute coronary syndrome: a review and current status
A Pradhan, A Tiwari, G Caminiti, C Salimei… - International Journal of …, 2022 - mdpi.com
… therapy of aspirin and a P2Y12 receptor inhibitor (clopidogrel… the need for more potent
P2Y12 inhibitors. We then describe … We try to rationalize the use of different P2Y12 inhibitors in …
P2Y12 inhibitors. We then describe … We try to rationalize the use of different P2Y12 inhibitors in …
Aspirin-free antiplatelet strategies after percutaneous coronary interventions
P Capranzano, D Moliterno… - European Heart …, 2024 - academic.oup.com
… The other studies of the first group have shown that P2Y12 inhibitor monotherapy following
… have shown that P2Y12 inhibitor monotherapy (clopidogrel or ticagrelor) vs. aspirin was …
… have shown that P2Y12 inhibitor monotherapy (clopidogrel or ticagrelor) vs. aspirin was …
Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!
CL Grines, JJ Marshall - European Heart Journal, 2019 - academic.oup.com
… with aspirin alone. More recently, there has been interest in shortening DAPT duration by
stopping aspirin … and may have reduced risk of gastrointestinal bleeding compared with aspirin. …
stopping aspirin … and may have reduced risk of gastrointestinal bleeding compared with aspirin. …
[HTML][HTML] P2Y12 inhibitor monotherapy: considerations for acute and long-term secondary prevention post-PCI
A Greco, MS Mauro, D Capodanno… - Reviews in …, 2022 - imrpress.com
… after randomly allocating 110 ACS patients undergoing PCI to receive either ticagrelor
monotherapy or DAPT with aspirin and ticagrelor for four weeks, with both strategies followed by …
monotherapy or DAPT with aspirin and ticagrelor for four weeks, with both strategies followed by …
Impact of P2Y12 inhibitors on clinical outcomes in sepsis-3 patients receiving aspirin: a propensity score matched analysis
S Jiang, J Xu, C Ke, P Huang - BMC Infectious Diseases, 2024 - Springer
… P2Y12 inhibitor is rarely administered alone, the target population in this study was limited to
septic patients using aspirin. … After that, the patients were divided into aspirin-alone group or …
septic patients using aspirin. … After that, the patients were divided into aspirin-alone group or …
Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes
JS Berger - The American journal of cardiology, 2013 - Elsevier
… In addition to the previously mentioned analysis by aspirin dose of the CURE data, comparing
clopidogrel plus aspirin with aspirin alone in patients with non–ST-segment elevation ACS …
clopidogrel plus aspirin with aspirin alone in patients with non–ST-segment elevation ACS …
[HTML][HTML] Comparative review of oral P2Y12 inhibitors
R Koski, B Kennedy - Pharmacy and Therapeutics, 2018 - ncbi.nlm.nih.gov
… inhibitors, aspirin alone was the standard antiplatelet regimen post-MI. The CURE trial compared
clopidogrel and aspirin (DAPT) to aspirin … events compared with aspirin in both trials. In …
clopidogrel and aspirin (DAPT) to aspirin … events compared with aspirin in both trials. In …
Effective platelet inhibition by aspirin and clopidogrel: where are we now?
… w17 More potent P2Y12 inhibition shifts the curve to the right with a resultant increase in the
… hepatic metabolism), polymorphisms in P2Y12 receptors or hepatic cytochromes, diabetes …
… hepatic metabolism), polymorphisms in P2Y12 receptors or hepatic cytochromes, diabetes …